Strategic Collaboration to Advance Biomedical Innovation

During Secretary General To Lam‘s official visit to Russia, coinciding with the 80th anniversary of Victory Day and the 75th anniversary of Vietnam-Russia diplomatic ties, a series of landmark agreements were signed, signaling a new era of cooperation in the biomedical field. These agreements aim to foster deep collaboration in high technology, with a particular emphasis on research, investment, technology transfer, and trade of cutting-edge biological medicines and vaccines.

Kirill Dmitriev and Mr. Ngo Chi Dung exchanging documents”>

VNVC’s Ambitious Pursuit: A Cancer Vaccine Breakthrough

At the forefront of VNVC’s objectives is the acquisition and development of a potential cancer vaccine, leveraging Russia’s recent advancements in this area. This initiative reflects a growing global urgency to combat cancer, which, according to the World Health Organization, is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 alone. The collaboration extends to a partnership with the National Center for Gamaleya Research on Epidemiology and Microbiology, focusing on joint scientific research and biotechnology development projects to be initiated promptly.

Thorough Partnerships: From Research to Production

VNVC has also established a collaborative agreement with Binnopharm, a leading Russian pharmaceutical manufacturer. this partnership aims to facilitate the transfer of technology for research, testing, and vaccine production, utilizing innovative RNA technology. The goal is to establish a “complete and closed” model for vaccine production in Vietnam, focusing on Binnopharm’s strengths and other key Russian pharmaceutical products, with a special emphasis on high-tech cancer diagnosis and treatment.

Expediting Access to Advanced Therapies

The agreement between the Russian Direct Investment Fund (RDIF) and VNVC is poised to accelerate the introduction of Russian-developed vaccines, including potential cancer vaccines, to Vietnamese patients. This includes facilitating clinical trials of biological medicines and advanced technology vaccines in Vietnam,which will streamline the registration,licensing,and marketing processes upon triumphant trial outcomes. This strategic move aims to provide Vietnamese citizens with early access to innovative medical solutions boasting high success rates.

This cooperation agreement opens opportunities for Vietnam to have early and integral access to new research and inventions in the fields of medicine and health care, helping people soon have access to new medications and technological vaccines, such as the possible Russian vaccine against the treatment of cancer that uses RNM technology.

Background: Russia’s Pioneering Cancer Vaccine Research

In December 2024, Russia’s National Center for Medical Research of Radiology announced its ongoing examination and development of a potential lung cancer vaccine, utilizing advanced RNA technology. This groundbreaking research underscores Russia’s commitment to innovation in cancer treatment and prevention,paving the way for potential breakthroughs in the global fight against this devastating disease.